Diet and Chemotherapy-Induced Peripheral Neuropathy: Emerging Evidence, Future Directions

October 21, 2026

Chemotherapy-induced peripheral neuropathy (CIPN) is a significant side effect of certain types of chemotherapies that impacts quality of life and treatment tolerance. Emerging observational evidence has highlighted the relationship between diet and the development and reduction of CIPN. This presentation will discuss this existing body of evidence and the mechanisms by which diet may impact CIPN, particularly CIPN caused by platinum-based chemotherapies. This presentation will also present an upcoming randomized control trial investigating diet to delay CIPN development and explore future directions.

Target Audience

 

Exercise oncology and oncology nutrition researchers, oncologists, registered dietitians, exercise physiologists, rehabilitation professionals, oncology nurses, and other healthcare professionals interested in the role of exercise and nutrition in comprehensive cancer care.

Learning Objectives

After participating in this activity, learners will be able to:
 
  • Describe the pathophysiology of chemotherapy-induced peripheral neuropathy and the potential mechanisms through which dietary factors may influence its development.
  • Summarize the current observational evidence regarding the relationship between diet and chemotherapy-induced peripheral neuropathy.
  • Discuss emerging research and future directions related to the use of dietary interventions for the prevention and management of chemotherapy-induced peripheral neuropathy.

Course summary

Available credit: 
  • 1.00 AMA PRA Category 1 Credit™
    The George Washington University School of Medicine and Health Sciences is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
  • 1.00 Completion
Course opens: 
10/21/2026
Course expires: 
12/31/2027
Event starts: 
10/21/2026 - 3:00pm EDT
Event ends: 
10/21/2026 - 4:00pm EDT
Add to calendar: 
Faculty & Disclosure
 
Planning Committee
 
Bao Duong, MPH
Research Center Associate
The Biostatistics Center| Milken Institute School of Public Health
ENICTO & DPPOS Coordinating Center
The George Washington University
 
Kimberly Robien, PhD, MS
Associate Research Professor
Exercise and Nutrition Sciences, Epidemiology
Milken Institute School of Public Health
The George Washington University
 
Faculty
 
Stephanie L.E. Compton, PhD, RD
Research Scientist Postdoctoral Research, Translational Research
AdventHealth
 
 
Disclosure of Relevant Financial Relationships
 
In accordance with The Standards for Integrity and Independence, GW requires all planners, faculty, and others in control of educational content to disclose the absence or existence of all financial relationships (of any dollar amount) with any ineligible companies within the past 24 months. We define ineligible companies as those whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.
 
GW reviews all disclosure statements to determine which financial relationships are relevant to the educational content of the CE Activity.  An individual is considered to have a relevant financial relationship if the educational content an individual can control is related to the business lines or products of the ineligible company.
 
Disclosure Statement(s)
 
Absence of Relevant Financial Relationships
 
None of the planners, faculty, or others in a position to control content for this educational activity have relevant financial relationship(s) to disclose with ineligible companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.
 
Disclaimer
 
The information in this educational activity is provided for general medical education purposes only and is not meant to substitute for the independent medical judgment of a physician relative to diagnostic and treatment options of a specific patient’s medical condition. The viewpoints expressed in this CME activity are those of the authors/faculty. They do not represent an endorsement by The George Washington University.
 
 

 

 
 
 
Accreditation Statements
 
The George Washington University School of Medicine and Health Sciences is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
 
Credit Designation Statement(s)
 
Physicians (CME)
 
The George Washington University School of Medicine and Health Sciences designates this live activity for a maximum of 1.00 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
 
Other Healthcare Professionals (Attendance)
 
All other healthcare professionals who successfully complete the activity will receive a Certificate of Attendance.  Many credentialing bodies such as the ANCC, AANP, and AAPA accept certificates of attendance for educational activities certified for AMA PRA Category 1 Credit(s)™ from organizations accredited by the ACCME. If you have doubts about whether an activity will qualify for CE, please contact your certifying organization for clarification on credit eligibility.

 

 
 

Available Credit

  • 1.00 AMA PRA Category 1 Credit™
    The George Washington University School of Medicine and Health Sciences is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
  • 1.00 Completion
Please login or register to take this course.
Registration Instructions
 
Please note that you must be logged in to complete the CE credit claim process. 
 
New Users
 
You must create a learner account prior to claiming CE credit. 
 
Returning Users